Ask AI

Why Switch a Suppressive Regimen? Insights From the NCCC

Ongoing innovation in HIV antiretroviral therapy (ART) has led to more effective, better tolerated, and more convenient regimens than ever before, shifting contemporary HIV care toward an emphasis on ART individualization and optimization. Use this program to learn how to consistently and proactively reassess ART in people with virologically suppressed HIV to determine whether they would benefit from ART switch to a regimen better suited to their changing health, lifestyle, or circumstances.

Share

Program Content

Events

Activities

When and Why to Switch ART Slides
When and Why to Switch ART in Individuals With Virologically Suppressed HIV Slides
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with the Goldschmidt Collective.

Supporters

This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

Merck & Co., Inc., Rahway, NJ, USA

Partners

Goldschmidt Collective

ProCE Banner